A systematic review of the role of hydrolyzed infant formulas in allergy prevention

Archives of Pediatrics and Adolescent Medicine

Volumn 159, Issue 9, 2005, Pages 810-816

  Hays, Tiffani ^a   Wood, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN;

ARTIFICIAL MILK; ATOPY; BREAST FEEDING; CLINICAL TRIAL; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HUMAN; HYDROLYSIS; INCIDENCE; INFANT; INTERMETHOD COMPARISON; META ANALYSIS; MILK; MILK ALLERGY; NURSE; PHYSICIAN; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SOYBEAN MILK; SYMPTOM; SYSTEMATIC REVIEW;

CHILD, PRESCHOOL; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; INFANT; INFANT FORMULA; INFANT, NEWBORN; MILK HYPERSENSITIVITY; PROTEIN HYDROLYSATES;

EID: 24344472234     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.159.9.810     Document Type: Review

References (36)

1. Dean T. Prevalence of allergic disorders in early childhood. Pediatr Allergy Immunol. 1997;8(10, suppl):27-31.
2. Tariq SM, Matthews SM, Hakim EA, Stevens M, Arshad SH, Hide DW. The prevalence of and risk factors for atopy in early childhood: a whole population birth cohort study. J Allergy Clin Immunol. 1998;101:587-593.
3. Bousquet J, Burney P. Evidence of an increase in atopic disease and possible causes. Clin Exp Allergy. 1993;23:484-492.
4. Zeiger RS. Prevention of food allergy in infants and children. Immunol Allergy Clin North Am. 1999;19:619-646.
5. van Odijk J, Ahlstedt S, Bengtsson U, Hulthen L, Borres MP. Specific IgE antibodies to peanut in western Sweden [published correction appears in Allergy. 2001;56:1229]? Allergy. 2001;56:573-577.
6. Bergmann RL, Edenharter G, Bergmann KE, et al. Predictability of early atopy by cord blood-IgE and parental history. Clin Exp Allergy. 1997;27:752-760.
7. Croner S. Kjellman NI. Development of atopic disease in relation to family history and cord blood IgE levels. Pediatr Allergy Immunol. 1990;1:14-20.
8. Committee on Nutrition; American Academy of Pediatrics. Hypoallergenic infant formulas. Pediatrics. 2000;106(pt 1):346-349.
9. Host A, Koletzko B, Dreborg S, et al. Dietary products used in infants for treatment and prevention of food allergy: joint statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition. Arch Dis Child. 1999;81:80-84.
10. Kjellman NI. Atopic disease in seven-year-old children: incidence in relation to family history. Acta Paediatr Scand. 1977;66:465-471.
11. Zeiger RS, Heller S. The development and prediction of atopy in high-risk children. J Allergy Clin Immunol. 1995;95:1179-1190.
12. Strobel S. Dietary manipulation and induction of tolerance. J Pediatr. 1992;121(pt 2):S74-S79.
13. Vaarala O, Saukkonen T, Savilahti E, Klemola T, Akerblom HK. Development of immune response to cow's milk proteins in infants receiving cow's milk or hydrolyzed formula. J Allergy Clin Immunol. 1995;96(pt 1):917-923.
14. Fritsche R. Induction of oral tolerance to cow's milk proteins in rats fed with a whey protein hydrolysate. Nutr Res. 1998;18:1335-1341.
15. Marini A, Agosti M, Motta G, Mosca F. Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow-up. Acta Paediatr Suppl. 1996;414:1-21.
16. Vadas P, Wai Y, Burks W, Perelman B. Detection of peanut allergens in breast milk of lactating women. JAMA. 2001;285:1746-1748.
17. Lifschitz CH, Hawkins HK, Guerra C, Byrd N. Anaphylactic shock due to cow's milk protein hypersensitivity in a breast-fed infant. J Pediatr Gastroenterol Nutr. 1988;7:141-144.
18. Oldaeus G, Anjou K, Bjorksten B, Moran JR, Kjellman NI. Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Arch Dis Child. 1997;77:4-10.
19. Zeiger RS, Heller S, Mellon MH, et al. Effect of combined maternal and infant food-allergen avoidance on development of atopy in early infancy: a randomized study [published correction appears in J Allergy Clin Immunol. 1989;84(pt 1):677]. J Allergy Clin Immunol. 1989;84:72-89.
20. von Berg A, Koletzko S, Grubl A, et al. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life. J Allergy Clin Immunol. 2003;111:533-540.
21. Mallet E, Henocq A. Long-term prevention of allergic diseases by using protein hydrolysate formula in at-risk infants. J Pediatr. 1992;121(pt 2):S95-S100.
22. Chandra RK, Puri S, Hamed A. Influence of maternal diet during lactation and use of formula feeds on development of atopic eczema in high risk infants [published correction appears in BMJ. 1989;299:896]. BMJ. 1989;299:228-230.
23. Halken S, Host A, Hansen LG, Osterballe O. Preventive effect of feeding high-risk infants a casein hydrolysate formula or an ultrafiltrated whey hydrolysate formula: a prospective, randomized, comparative clinical study. Pediatr Allergy Immunol. 1993;4:173-181.
24. Halken S, Hansen KS, Jacobsen HP, et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective randomized study. Pediatr Allergy Immunol. 2000;11:149-161.
25. Porch MC, Shahane AD, Leiva LE, et al. Influence of breast milk, soy, or two hydrolyzed formulas on the development of allergic manifestations in infants at risk. Nutr Res. 1998;18:1413-1424.
26. Aggett PJ, Haschke F, Heine W, et al; ESPGAN Committee on Nutrition. Comment on antigen-reduced infant formulae. Acta Paediatr. 1993;82:314-319.
27. Chandra RK. Five-year follow-up of high-risk infants with family history of allergy who were exclusively breast-fed or fed partial whey hydrolysate, soy, and conventional cow's milk formulas. J Pediatr Gastroenterol Nutr. 1997;24:380-388.
28. Chandra RK, Hamed A. Cumulative incidence of atopic disorders in high-risk infants fed whey hydrolysate, soy, and conventional cow's milk formulas. Ann Allergy. 1991;67:129-132.
29. Marini A, Agosti M, Motta G. A dietary prevention program including whey hydrolyzed formula for high-risk atopic babies: 0-24 months follow-up. Dev Physiopathol Clin. 1990;1:131-141.
30. Willems R, Duchateau J, Magrez P, Denis R, Casimir G. Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Ann Allergy. 1993;71:147-150.
31. Vandenplas Y, Hauser B, Van den Borre C, Sacre L, Dab I. Effect of a whey hydrolysate: prophylaxis of atopic disease. Ann Allergy. 1992;68:419-424.
32. Vandenplas Y, Hauser B, Van den Borre C, et al. The long-term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. Eur J Pediatr. 1995;154:488-494.
33. Exl BM, Deland U, Wall M, et al. ZUG-Frauenfeld Nutritional Survey (ZUFF study): allergen reduced nutrition in a normal infant population and its health-related effects: results at the age of 6 months. Nutr Res. 1998;18:1443-1462.
34. Chan YH, Shek LP, Aw M, Quak SH, Lee BW. Use of hypoallergenic formula in the prevention of atopic disease among Asian children. J Paediatr Child Health. 2002;38:84-88.
35. Baumgartner M, Brown CA, Exl BM, et al. Controlled trials investigating the use of one partially hydrolyzed whey formula for dietary prevention of atopic manifestations until 60 months of age. Nutr Res. 1998;18:1425-1442.
36. Osborn DA, Sinn J. Formulas containing hydrolyzed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev. 2003;4:CD003664.